{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:06:32Z","timestamp":1775552792984,"version":"3.50.1"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,1]]},"DOI":"10.1093\/europace\/euw409","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T02:59:50Z","timestamp":1507949990000},"page":"1630-1636","source":"Crossref","is-referenced-by-count":17,"title":["Short-term dabigatran interruption before cardiac rhythm device implantation: multi-centre experience from the RE-LY trial"],"prefix":"10.1093","volume":"19","author":[{"given":"Vidal","family":"Essebag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Coutu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratika","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan H","family":"Hohnloser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Oldgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff S","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"key\n\t\t\t\t20171013225943_euw409-B1","first-page":"1571","article-title":"Device surgery without interruption of anticoagulation","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171013225943_euw409-B2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1160\/TH15-03-0247","article-title":"Dabigatran use in elderly patients with atrial fibrillation","volume":"115","year":"2015","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171013225943_euw409-B3","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjmed.2015.07.013","article-title":"Antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation: the GLORIA-AF Registry, Phase II","volume":"128","year":"2015","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20171013225943_euw409-B4","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.clinthera.2015.09.008","article-title":"Trends in prescribing oral anticoagulants in Canada, 2008-2014","volume":"37","year":"2015","journal-title":"Clin Ther"},{"key":"key\n\t\t\t\t20171013225943_euw409-B5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171013225943_euw409-B6","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00228-013-1510-z","article-title":"Novel oral anticoagulants: clinical pharmacology, indications and practical considerations","volume":"69","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"key\n\t\t\t\t20171013225943_euw409-B7","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/heartjnl-2012-301841","article-title":"New anticoagulant treatments to protect against stroke in atrial fibrillation","volume":"98","year":"2012","journal-title":"Heart"},{"key":"key\n\t\t\t\t20171013225943_euw409-B8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1502000","article-title":"Idarucizumab for dabigatran reversal","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171013225943_euw409-B9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial","volume":"126","year":"2012","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171013225943_euw409-B10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ahj.2009.02.005","article-title":"Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran","volume":"157","year":"2009","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171013225943_euw409-B11","first-page":"123","article-title":"Significance tests for 2 X 2 tables","volume":"34","year":"1947","journal-title":"Biometrika"},{"key":"key\n\t\t\t\t20171013225943_euw409-B12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171013225943_euw409-B13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/europace\/euv190","article-title":"Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Society (APHRS)","volume":"17","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20171013225943_euw409-B14","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS"},{"issue":"Suppl 1","key":"key\n\t\t\t\t20171013225943_euw409-B15","first-page":"9S","article-title":"Pharmacology, pharmacokinetics, and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor","volume":"15","year":"2009","journal-title":"Clin Appl Thromb-Hemost"},{"key":"key\n\t\t\t\t20171013225943_euw409-B16","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.005754","article-title":"Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)","volume":"129","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171013225943_euw409-B17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1111\/jce.12214","article-title":"Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin","volume":"24","year":"2013","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key\n\t\t\t\t20171013225943_euw409-B18","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1253\/circj.CJ-14-0665","article-title":"Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"key\n\t\t\t\t20171013225943_euw409-B19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2012.12.046","article-title":"Safety of continuous anticoagulation with dabigatran during implantation of cardiac rhythm devices","volume":"111","year":"2013","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20171013225943_euw409-B20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2015.12.007","article-title":"Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: the BRUISE CONTROL-2 trial","volume":"173","year":"2016","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20171013225943_euw409-B21","first-page":"1461","article-title":"Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies","volume":"19","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key\n\t\t\t\t20171013225943_euw409-B22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pace.12557","article-title":"Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study","volume":"38","year":"2015","journal-title":"Pacing Clin Electrophysiol"},{"key":"key\n\t\t\t\t20171013225943_euw409-B23"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/19\/10\/1630\/20917289\/euw409.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T16:26:17Z","timestamp":1659630377000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/europace\/article\/19\/10\/1630\/3052246\/Shortterm-dabigatran-interruption-before-cardiac"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,2,23]]},"published-print":{"date-parts":[[2017,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw409","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10]]},"published":{"date-parts":[[2017,2,23]]}}}